Factors predicting growth of vestibular schwannoma in neurofibromatosis type 2

Neurosurgical Review

Volumn 32, Issue 4, 2009, Pages 425-433

  Ito, Eiji ^a   Saito, Kiyoshi ^b   Yatsuya, Hiroshi ^a   Nagatani, Tetsuya ^a   Otsuka, Goro ^c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

Neurofibromatosis type 2; Predictive factors; Vestibular schwannoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MALE; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RADIOSURGERY; TUMOR GROWTH;

ADOLESCENT; ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; CRANIAL NERVE NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; NEUROSURGICAL PROCEDURES; PREDICTIVE VALUE OF TESTS; RADIOSURGERY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TRIGEMINAL NERVE; YOUNG ADULT;

EID: 69949159299     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-009-0223-3     Document Type: Article

References (23)

1. GA Rouleau P Merel M Lutchman, et al. 1993 Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 Nature 363 515 521
2. JA Trofatter MM [tmp] MacCollin JL Rutter, et al. 1993 A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor Cell 72 791 800
3. LI Malis 1998 Neurofibromatosis type 2 and central neurofibromatosis Neurosurg Focus 4 3 e1
4. The Consensus Development Panel 1994 National Institutes of Health Consensus Development Conference-Statement on Acoustic Neuroma, December 11-13, 1991 Arch Neurol 51 201 207
5. PH Aguiar M Tatagiba M Samii E Dankoweit-Timpe H Ostertag 1995 The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB 1 Acta Neurochir 134 40 45
6. DG Evans ME Baser B O'Reilly, et al. 2005 Management of the patient and family with neurofibromatosis 2: a consensus conference statement Br J Neurosurg 19 5 12
7. ME Baser EV Makariou DM Parry 2002 Predictors of vestibular schwannoma growth in patients with neurofibromatosis type 2 J Neurosurg 96 217 222
8. VF Mautner ME Baser SD Thakkar, et al. 2002 Vestibular schwannoma growth in patients with neurofibromatosis type 2: a longitudinal study J Neurosurg 96 223 228
9. DG Evans SM Huson D Donnai, et al. 1992 A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity J Med Genet 29 841 846
10. VF Mautner M Lindenau ME Baser, et al. 1996 The neuroimaging and clinical spectrum of neurofibromatosis 2 Neurosurgery 38 880 885
11. G Otsuka K Saito T Nagatani J Yoshida 2003 Age at symptom onset and long-term survival in patients with neurofibromatosis type 2 J Neurosurg 99 480 483
12. ME Baser JM Friedman D Aeschliman, et al. 2002 Predictors of the risk of mortality in neurofibromatosis 2 Am J Hum Genet 71 715 723
13. DG Evans L Trueman A Wallace S Collins T Strachan 1998 Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations J Med Genet 35 450 455
14. L Kluwe S Bayer ME Baser, et al. 1996 Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes Hum Genet 98 534 538
15. L Kluwe M [tmp] MacCollin M Tatagiba, et al. 1998 Phenotypic variability associated with 14 splice-site mutations in the NF2 gene Am J Med Genet 77 228 233
16. DM Parry MM [tmp] MacCollin MI Kaiser-Kupfer, et al. 1996 Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities Am J Hum Genet 59 529 539
17. MH Ruttledge AA Andermann CM Phelan, et al. 1996 Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease Am J Hum Genet 59 331 342
18. ME Baser L Kuramoto R Woods, et al. 2005 The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 J Med Genet 42 540 546
19. BR Subach D Kondziolka LD Lunsford, et al. 1999 Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis type 2 J Neurosurg 90 815 822
20. RA Sobel 1993 Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases J Neuropathol Exp Neurol 52 106 113
21. Y Hamada T Iwaki M Fukui, et al. 1997 A comparative study of embedded nerve tissue in six NF2-associated schwannomas and 17 nonassociated NF2 schwannomas Surg Neurol 48 395 400
22. J Jaaskelainen A Paetau I Pyykko, et al. 1994 Interface between the facial nerve and large acoustic neurinomas. Immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases J Neurosurg 80 541 547
23. M Samii C Matthies M Tatagiba 1997 Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2 Neurosurgery 40 696 705